Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2021 03:00 ET | Source: Vaccitech Limited

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP-300 Immunotherapeutic Candidate for Chronic HBV Patients

OXFORD, United Kingdom, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines...
November 23, 2020 03:23 ET | Source: Vaccitech Limited

Oxford University breakthrough on global COVID-19 vaccine

OXFORD, United Kingdom, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of...